Medy-Tox Inc. (KOSDAQ:086900)
South Korea flag South Korea · Delayed Price · Currency is KRW
119,800
+300 (0.25%)
Aug 29, 2025, 9:39 AM KST

Medy-Tox Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Operating Revenue
234,632228,622221,121195,096184,870140,828
Upgrade
Other Revenue
----0-0-
Upgrade
234,632228,622221,121195,096184,870140,828
Upgrade
Revenue Growth (YoY)
-4.72%3.39%13.34%5.53%31.27%-31.60%
Upgrade
Cost of Revenue
99,83590,03887,62569,04879,39766,928
Upgrade
Gross Profit
134,798138,584133,496126,048105,47373,900
Upgrade
Selling, General & Admin
76,19278,37086,60547,67941,93859,544
Upgrade
Research & Development
29,82129,82125,13323,32423,26732,544
Upgrade
Other Operating Expenses
1,3461,3461,3221,2421,2161,403
Upgrade
Operating Expenses
116,057118,236116,17379,38372,335110,969
Upgrade
Operating Income
18,74020,34917,32246,66533,138-37,070
Upgrade
Interest Expense
-1,727-1,727-2,333-2,314-4,781-4,176
Upgrade
Interest & Investment Income
925.15925.15896.43610.76957.22340.02
Upgrade
Earnings From Equity Investments
6,7655,8771,3635,129-1,456-2,432
Upgrade
Currency Exchange Gain (Loss)
4,3874,387475.223,4252,111-376.81
Upgrade
Other Non Operating Income (Expenses)
-3,440-4,138-605.87-715.84108,4316,967
Upgrade
EBT Excluding Unusual Items
25,65125,67317,11852,800138,400-36,748
Upgrade
Impairment of Goodwill
------711.12
Upgrade
Gain (Loss) on Sale of Investments
126.49126.49-593.36-3,0442,666-1,067
Upgrade
Gain (Loss) on Sale of Assets
323.58323.58-671.97-230.42131.4858.63
Upgrade
Asset Writedown
-8,624-8,624---12,932-3,671
Upgrade
Pretax Income
17,47717,49915,85349,526128,265-42,139
Upgrade
Income Tax Expense
-247.331,4256,16312,93035,003-12,100
Upgrade
Earnings From Continuing Operations
17,72416,0749,69036,59693,263-30,039
Upgrade
Minority Interest in Earnings
1,469881.2265.28414.16891.27462.11
Upgrade
Net Income
19,19316,9559,75537,01094,154-29,577
Upgrade
Preferred Dividends & Other Adjustments
975975975975.33974.730.7
Upgrade
Net Income to Common
18,21815,9808,78036,03593,179-29,577
Upgrade
Net Income Growth
244.57%73.81%-73.64%-60.69%--
Upgrade
Shares Outstanding (Basic)
677766
Upgrade
Shares Outstanding (Diluted)
677766
Upgrade
Shares Change (YoY)
-2.69%0.40%2.02%2.28%0.04%-0.82%
Upgrade
EPS (Basic)
2832.892376.571311.065491.6814587.59-4609.95
Upgrade
EPS (Diluted)
2832.892376.571311.005489.3414517.37-4610.30
Upgrade
EPS Growth
307.46%81.28%-76.12%-62.19%--
Upgrade
Free Cash Flow
46,24427,8305,86216,3042,452-13,217
Upgrade
Free Cash Flow Per Share
7191.044138.95875.312483.66382.01-2059.99
Upgrade
Dividend Per Share
1100.0001100.000----
Upgrade
Gross Margin
57.45%60.62%60.37%64.61%57.05%52.48%
Upgrade
Operating Margin
7.99%8.90%7.83%23.92%17.93%-26.32%
Upgrade
Profit Margin
7.76%6.99%3.97%18.47%50.40%-21.00%
Upgrade
Free Cash Flow Margin
19.71%12.17%2.65%8.36%1.33%-9.38%
Upgrade
EBITDA
38,85240,30732,69861,76651,394-18,472
Upgrade
EBITDA Margin
16.56%17.63%14.79%31.66%27.80%-13.12%
Upgrade
D&A For EBITDA
20,11219,95915,37615,10118,25618,597
Upgrade
EBIT
18,74020,34917,32246,66533,138-37,070
Upgrade
EBIT Margin
7.99%8.90%7.83%23.92%17.93%-26.32%
Upgrade
Effective Tax Rate
-8.15%38.88%26.11%27.29%-
Upgrade
Advertising Expenses
-7,1465,9763,3512,0313,839
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.